Exhale Coffee did not arrive at the Advertising Standards Authority empty-handed. The company referred to scientific research, independent laboratory certificates and antioxidant test data; its production process had been designed to maximise polyphenols and antioxidants; and it said that a recommended serving contained enough magnesium and potassium to meet the thresholds for authorised claims relating to those nutrients.
Even so, a paid Instagram advertisement breached the CAP Code. The ASA’s ruling found that the ad contained unauthorised specific health claims, general health claims without an accompanying authorised claim, impermissible nutrition claims and health claims referring to the recommendation of an individual health professional. Both issues investigated were upheld.
The ruling is a useful study in how regulated claims fail. Exhale had supporting material, but its evidence, the claims available under the rules and the meaning communicated to consumers did not match.
For marketing and compliance leaders, that distinction matters well beyond food advertising. A claim can be scientifically plausible, carefully researched and sincerely made, yet still be unavailable for commercial use.
The ad assembled a larger promise than any single sentence
The Instagram post, seen on 19 February 2026, featured Exhale’s founder discussing telomeres: protective structures at the ends of chromosomes that shorten as cells divide.
He referred to research involving NHS nurses and said moderate coffee drinkers had telomeres equivalent to those of people five years younger. The script then moved from an observed association to a product benefit. Coffee was described as “buying you time” and “protecting your DNA”, while polyphenols and antioxidants were presented as the likely explanation.
Exhale then connected that research to its product, saying conventional roasting could remove protective compounds and describing its own process, involving nine independent laboratory tests, as a way to produce coffee rich in polyphenols and antioxidants. The accompanying caption referred to broad health benefits and support for gut and brain health.
Each element had a role: the study created authority, the biological mechanism made the benefit intelligible, the laboratory testing connected the research to the product, the founder made the argument accessible and the medical involvement added reassurance.
Together, they turned an account of coffee science into a product promise. The ASA considered that consumers were likely to understand the ad as saying that the product, particularly its antioxidants, could slow ageing by protecting telomeres, and classified that message as a specific health claim.
This is where claims review often becomes too narrow. A reviewer may assess the study reference, product description, caption and expert biography as separate components, while the audience encounters one advertisement whose regulated claim is the meaning created by the finished communication.
The register determines which claim is available
The CAP Code defines a health claim as one that states, suggests or implies a relationship between a food, food category or constituent and health. Only health claims authorised in the applicable register, or wording with the same consumer meaning, may be used. Nutrition claims must also be listed in the register, and any conditions attached to a claim must be met.
For marketing in England, Scotland and Wales, the relevant source is the Great Britain Nutrition and Health Claims Register. It contains authorised and rejected nutrition and health claims. Only authorised claims may be used in Great Britain, subject to the applicable rules and conditions.
Exhale referred to an authorised health claim for polyphenols. That claim concerned olive-oil polyphenols and the protection of blood lipids from oxidative stress. It did not apply to polyphenols in coffee, nor did it describe the telomere, DNA, ageing, gut or brain benefits conveyed by the advertisement.
The company’s evidence about magnesium and potassium could not supply a regulatory basis for those wider messages either. Exhale said two cups contained enough of the nutrients to meet thresholds for authorised claims, but the advertisement did not make the relevant magnesium or potassium claims. The existence of a potentially available claim elsewhere in the register could not support a different claim in the creative.
Evidence and authorisation answer different questions. Evidence can show that a product has a particular composition or meets the conditions attached to a claim; the register determines which health or nutritional benefit may be communicated; and the advertisement determines what consumers are actually being told. A laboratory report may establish the first point while doing nothing to resolve the other two.
The mismatch extended to Exhale’s more general language. Under rule 15.2 of the CAP Code, a reference to the general benefits of a food or nutrient for overall health or health-related wellbeing is acceptable only when accompanied by a relevant, specific authorised health claim.
The ASA treated descriptions of the product as especially healthy, references to broad health benefits and statements about gut and brain health as general health claims. It also found that the longevity narrative suggested an overall benefit by implying that the coffee could extend lifespan, yet none of those messages was accompanied by a relevant authorised specific claim.
This removes a common escape route for marketers. Softer language does not necessarily reduce the regulatory burden because words such as healthy, beneficial and supportive can still communicate a relationship between the product and health. Nutrition language creates a similar risk: the ASA considered “high in antioxidants and polyphenols” to be nutrition claims because consumers would understand the wording as describing beneficially high levels of those substances. Neither claim identified a specific nutrient to which an authorised nutrition claim might apply, so the claims were not permitted.
A seemingly ordinary adjective can change the regulatory character of a sentence. “Contains polyphenols” describes composition. “High in polyphenols” presents that composition as a beneficial nutritional property. The difference is small on the page and material under the Code.
The second upheld issue concerned Dr Rupy, described in the advertisement as the founder of The Doctor’s Kitchen and Exhale’s Director and Chief Science Officer.
Exhale said his participation reflected his genuine role in the business and his shared interest in the company’s approach to food production. The ASA still considered that consumers were likely to interpret his involvement in product development and his position within the company as an endorsement.
That interpretation mattered because rule 15.6.3 prohibits health claims that refer to the recommendation of an individual health professional.
The case does not prevent health professionals from appearing in food advertising, but it does show that their credentials, role and presentation cannot be treated as neutral context when the communication also makes health claims.
For expert-led businesses, this is an important distinction. A doctor or scientist may have made a genuine and substantial contribution to product development, yet the commercial value of displaying that expertise comes from the authority it conveys to consumers. That authority can cause the presentation to become a prohibited recommendation.
Names, biographies and job titles therefore belong inside the claims review. They are part of the meaning of the asset, not administrative information sitting around it.
The weakest point is often the handover between teams
The Exhale ruling exposes a familiar organisational problem. The information required to make a sound decision may exist, but not in a form that can be applied reliably during content development.
Product teams hold formulation data and laboratory results, regulatory affairs understands the register and conditions of use, marketing develops the consumer proposition, an agency or creator adapts it for social media, a founder or specialist appears on camera and compliance receives the completed asset close to publication. Each participant sees part of the claim, but few see its full provenance.
A spreadsheet containing approved wording and a link to a study will not solve this. A reusable claim needs its boundaries attached: the authorised wording, the product or constituent to which it applies, the conditions that must be satisfied, the evidence demonstrating those conditions and the contexts that could alter its meaning.
It should also preserve the judgement behind the decision: why the variation was accepted, which broader statements can accompany it, whether a change of channel requires another review and whether an expert endorsement, comparison or visual could move the communication beyond the original approval.
Without that record, institutional knowledge remains dependent on individual memory. A marketer reuses language because it appeared in a previous campaign. A reviewer repeats an earlier decision without seeing the factual distinction. Another team finds the evidence but not the reasoning that connected it to the approved claim.
Traceability improves the next decision while also producing an audit trail after the event.
Generative AI can convert a research paper, product specification or expert interview into scripts, captions, landing pages and advertising variants within minutes.
The risk is not confined to fabricated evidence. A model can preserve the source accurately while changing the regulatory meaning.
It may turn an association observed in research into a benefit of the advertised product, transfer a claim from one constituent or food to another, replace an authorised formulation with language that no longer carries the same consumer meaning, or combine several cautious statements into a stronger overall impression. These are failures of context and judgement rather than grammar.
Giving an AI system access to a folder of research will not prevent them. Useful support for regulated marketing also requires the approved claim set, product information, conditions of use, relevant policies, previous decisions and clear routes for specialist review.
The aim is to make expert judgement easier to apply consistently by retrieving the right authority, identifying where the creative has moved beyond it and preserving the reasoning behind the final decision, without automating the regulatory conclusion.
AI can amplify expertise when that expertise has been made available to the workflow. Without it, AI amplifies the distance between source material and consumer promise.
Build the claim before building the campaign
The ASA required Exhale’s advertisement not to appear again in the form complained of. It told the company to ensure that future specific health and nutrition claims were authorised on the GB register and met their conditions of use, that general health claims were accompanied by a relevant authorised specific claim and that health claims did not refer to the recommendation of a health professional.
The practical response is to establish the regulatory route before the scientific story hardens into a campaign. Marketing should know which claims are genuinely available to the product, what the evidence proves and where the permitted meaning ends. Compliance and regulatory affairs should make that judgement accessible early enough to shape the creative, with product evidence, authorised wording and presentation constraints travelling together.
This gives marketing confidence to work within known boundaries, reduces the time specialists spend reconstructing claims at the end of the process and speeds decisions by reusing knowledge from earlier investigations.
The Exhale Coffee ruling is a reminder that a well-supported story is not necessarily an authorised one, and that organisations need to know the difference before publication.
What teams need to know
What did the ASA decide in the Exhale Coffee ruling?
The ASA upheld both issues investigated. It found that the paid Instagram ad contained unauthorised specific health and nutrition claims, general health claims without an accompanying relevant authorised claim and health claims referring to the recommendation of an individual health professional.
Did the ASA decide that coffee cannot affect telomeres?
No. The ruling assessed whether the advertising claims were permitted under the CAP Code. The ASA found no authorised claim in the GB Nutrition and Health Claims Register supporting the telomere, DNA, ageing or longevity benefits communicated for Exhale’s product. It did not make a broader finding about all scientific research concerning coffee and telomeres.
Why was Exhale’s laboratory evidence insufficient?
The testing could provide evidence about the product’s composition. It could not authorise a health or nutrition claim that was absent from the register or applied to a different food, constituent or benefit. The permitted claim, conditions of use and consumer message must correspond.
Can a food brand describe a product as healthy?
A general claim about overall health or health-related wellbeing must be accompanied by a relevant specific authorised health claim. Broad wording does not provide an alternative to the GB register.
Can a doctor or other health professional endorse a food product?
The CAP Code prohibits health claims that refer to the recommendation of an individual health professional. A genuine employment, directorship or product-development role does not remove the risk when consumers are likely to understand the presentation as an endorsement.